(19)
(11) EP 1 675 871 A2

(12)

(88) Date of publication A3:
24.11.2005

(43) Date of publication:
05.07.2006 Bulletin 2006/27

(21) Application number: 04795967.1

(22) Date of filing: 12.10.2004
(51) International Patent Classification (IPC): 
C07K 14/525(1995.01)
(86) International application number:
PCT/US2004/034880
(87) International publication number:
WO 2005/035564 (21.04.2005 Gazette 2005/16)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 10.10.2003 US 510430 P

(71) Applicant: Xencor Inc.
Monrovia, CA 91016 (US)

(72) Inventors:
  • DESJARLAIS, John, R.
    Pasadena, CA 91104 (US)
  • STEED, Paul, Michael
    Chapel Hill, NC 27516 (US)
  • ZALEVSKY, Jonathan
    Riverside, CA 92058 (US)
  • SZYMKOWSKI, David, Edmund
    Monrovia, CA 91016 (US)

(74) Representative: Kiddle, Simon John et al
Mewburn Ellis LLP York House, 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) PROTEIN BASED TNF-ALPHA VARIANTS FOR THE TREATMENT OF TNF-ALPHA RELATED DISORDERS